(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 11.73% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 6.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.56%.
Cognex's revenue in 2025 is $914,515,000.On average, 3 Wall Street analysts forecast CGNX's revenue for 2025 to be $171,078,555,198, with the lowest CGNX revenue forecast at $169,525,982,572, and the highest CGNX revenue forecast at $173,772,625,422. On average, 2 Wall Street analysts forecast CGNX's revenue for 2026 to be $193,064,274,561, with the lowest CGNX revenue forecast at $191,462,440,878, and the highest CGNX revenue forecast at $194,666,108,244.
In 2027, CGNX is forecast to generate $217,937,711,062 in revenue, with the lowest revenue forecast at $217,937,711,062 and the highest revenue forecast at $217,937,711,062.